Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 6Observational 1

Sponsor

Conditions

Supranuclear Palsy, Progressive 1Spinal Cord Injuries 1Parkinson Disease 1Myasthenia Gravis 1Multiple System Atrophy 1Lewy Body Disease 1Essential Tremor 1Alzheimer Disease 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 405Surgical Procedures, Operative 151Interviews as Topic 131Radiotherapy 130Observation 122Drug Therapy 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 58Watchful Waiting 51Immunotherapy 51Bevacizumab 49Positron Emission Tomography Computed Tomography 46Ultrasonography 44Liquid Biopsy 41Hematologic Tests 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Observational × Neurofeedback × Clear all
NCT02761707 2019-07-18

Biomarkers in Neural Disorders

University of Pennsylvania

Completed
54 enrolled

Alzheimer Disease, Myasthenia Gravis, Parkinson Disease, Spinal Cord Injuries, Supranuclear Palsy, Progressive, Multiple System Atrophy, Essential Tremor, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡